Citius Oncology, Inc. CTOR Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s deferred taxes?
- Citius Oncology, Inc. (CTOR) reported deferred taxes of $2.82M in Q1 2026.
- How has Citius Oncology, Inc.'s deferred taxes changed year-over-year?
- Citius Oncology, Inc.'s deferred taxes increased by 24.9% year-over-year, from $2.26M to $2.82M.
- What is the long-term trend for Citius Oncology, Inc.'s deferred taxes?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s deferred taxes has grown at a 55.5% compound annual growth rate (CAGR), from $1.15M to $2.78M.
- What does deferred taxes mean?
- This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.